Studies have shown that FN binding to tumor cell membrane integrins can activate downstream signaling pathways such as the integrin-linked kinase (ILK) and NF-κΒ pathways, thereby regulating the expression of EMT-related genes in lung cancer [24, 25]. The gene discussed is ILK; the disease is lung carcinoma.